Answer
The interaction risk with warfarin is highest during the week following each of the first two glofitamab (Columvi) doses, given on Cycle 1 Days 8 and 15, and patients taking warfarin should be monitored when Columvi is initiated.
Sources for this answer
- Columvi 2.5 mg, 10 mg concentrate for solution for infusionRoche Products Limited · emc · SmPC §4.5 Interaction with other medicinal products · Version 6Document updated
Sources checked